USP9X and neoplasm: USP9X is able to suppress tumor proliferation and EMT by activating the Hippo pathway by deubiquitinating and increasing the stability of LATS (Toloczko et al., 2017), and miR-212 downregulates USP9X by attaching to its 3′UTR (Chen et al., 2019).